Viewray
Oakwood Village, US · Founded 2013 · Delaware corporation · 3 known investors
ViewRay develops MRIdian A3i, an MRI-guided radiation therapy system that uses diagnostic-quality MRI imaging for real-time tissue tracking and automated beam control during cancer treatment. The system is used by hospitals and cancer centers to treat pancreas, prostate, lung, liver, breast, and oligometastatic cancers.
Founders & leadership
Viewray was founded in 2013 by James F. Dempsey.
JF
James F. DempseyFounder
DC
David ChandlerMr. Chandler is the Chief Financial Officer of the Issuer.
CA
Chris A. RaanesExecutive
MB
Michael BrandtExecutive
DD
D. David ChandlerExecutive
PR
Peter RoemerNamed on SEC filing
JD
James DempseySecretary of the Issuer.
GM
Gregory M. AyersPresident and Chief Executive Officer of the Issuer.
JA
Jay AndrewNamed on SEC filing
Board
JB
MR
Mark RoemerBoard director
DB
Investors · 3
Reported raises · per SEC filings
Form D private placements$126.9M disclosed across 7 of 8 rounds · 2012–2017
▶$26.1MraisedFeb 2017 · 12 investors · Other TechnologyRule 506(b)
▶$26.1MraisedFeb 2017 · 12 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Joshua BilenkerDirector
- Douglas H. KeareExecutive Officer
- Theodore T. WangDirector
- Brian K. RobertsDirector
- Mark S. GoldDirector
- Aditya PuriDirector
- Michael CogswellExecutive Officer
- James F. DempseyExecutive Officer, Director
- Henry A. McKinnell, Jr.Director
- Chris A. RaanesExecutive Officer, Director
- Ajay BansalExecutive Officer
- David BonitaDirector
- Caley CasteleinDirector
- Offering amount
- $26.1M
- Amount sold
- $26.1M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$13.8MraisedSep 2016 · 12 investors · Other TechnologyRule 506(b)
▶$13.8MraisedSep 2016 · 12 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Douglas H. KeareExecutive Officer
- Henry A. McKinnell, Jr.Director
- David BonitaDirector
- Brian K. RobertsDirector
- Mark S. GoldDirector
- Michael CogswellExecutive Officer
- Joshua BilenkerDirector
- Aditya PuriDirector
- Ajay BansalExecutive Officer
- Chris A. RaanesExecutive Officer, Director
- Caley CasteleinDirector
- James F. DempseyExecutive Officer, Director
- Offering amount
- $13.8M
- Amount sold
- $13.8M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$2.7MraisedAug 2015 · 60 investors · Other TechnologyRule 506(b)
▶$2.7MraisedAug 2015 · 60 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Joshua BilenkerDirector
- Michael BrandtExecutive Officer
- Caley CasteleinDirector
- Chris A. RaanesExecutive Officer, Director
- James F. DempseyExecutive Officer, Director
- Aditya PuriDirector
- David BonitaDirector
- D. David ChandlerExecutive Officer
- Mark S. GoldDirector
- Offering amount
- $2.7M
- Amount sold
- $2.7M
- Minimum investment
- $10K
- Sales commissions
- $217.5K
- Placement agents
- MLV & Co. LLC, American Portfolios Financial Services, Inc., Dinosaur Securities LLC, Katalyst Securities LLC
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶Undisclosed amountofferedAug 2015 · 90 investors · Other TechnologyRule 506(b)
▶Undisclosed amountofferedAug 2015 · 90 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- James DempseyExecutive Officer, Director
- Michael BrandtExecutive Officer
- D. David ChandlerExecutive Officer
- Caley CasteleinDirector
- Chris RaanesExecutive Officer, Director
- Mark GoldDirector
- Joshua BilenkerDirector
- David BonitaDirector
- Aditya PuriDirector
- First sale
- Jul 2015
- Incorporated
- Corporation, Nevada, 2013
- Federal exemptions
- 06b
▶$26.7MraisedAug 2015 · 115 investors · Other TechnologyRule 506(b)
▶$26.7MraisedAug 2015 · 115 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- James F. DempseyExecutive Officer, Director
- David BonitaDirector
- Joshua BilenkerDirector
- Michael BrandtExecutive Officer
- Aditya PuriDirector
- Mark S. GoldDirector
- D. David ChandlerExecutive Officer
- Chris A. RaanesExecutive Officer, Director
- Caley CasteleinDirector
- Offering amount
- $26.7M
- Amount sold
- $26.7M
- Minimum investment
- $10K
- Sales commissions
- $951K
- Placement agents
- American Portfolios Financial Services, Inc., Northland Securities, Inc., Katalyst Securities LLC, Trout Capital LLC, MLV & Co. LLC, Dinosaur Securities LLC
- First sale
- Jul 2015
- Incorporated
- Corporation, Nevada, 2013
- Federal exemptions
- 06b
▶$15MraisedMar 2015 · 1 investors · Other TechnologyRule 506(b)
▶$15MraisedMar 2015 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- James F. DempseyExecutive Officer, Director
- Mark RoemerDirector
- Chris A. RaanesExecutive Officer, Director
- Mark GoldDirector
- Caley CasteleinDirector
- Joshua BilenkerDirector
- Philip YangDirector
- David BonitaDirector
- Robert WeisskoffDirector
- David ChandlerExecutive Officer
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.3MraisedJan 2015 · 10 investors · Other TechnologyRule 506(b)
▶$16.3MraisedJan 2015 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David ChandlerExecutive Officer
- Joshua BilenkerDirector
- Mark RoemerDirector
- David BonitaDirector
- Robert WeisskoffDirector
- Philip YangDirector
- Caley CasteleinDirector
- Mark GoldDirector
- Chris A. RaanesExecutive Officer, Director
- James F. DempseyExecutive Officer, Director
- Offering amount
- $16.8M
- Amount sold
- $16.3M
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$26.3MraisedMar 2012 · 18 investors · Other TechnologyRule 506(b)
▶$26.3MraisedMar 2012 · 18 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David BonitaDirector
- Peter RoemerDirector
- David ChandlerExecutive Officer
- James DempseyExecutive Officer, Director
- Gregory M. AyersExecutive Officer, Director, Promoter
- Mark GoldDirector
- Robert WeisskoffDirector
- Jay AndrewDirector
- Joshua BilenkerDirector
- Caley CasteleinDirector
- Offering amount
- $26.3M
- Amount sold
- $26.3M
- First sale
- Mar 2012
- Incorporated
- Corporation, Delaware, 2007
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Viewray do?
- ViewRay develops MRIdian A3i, an MRI-guided radiation therapy system that uses diagnostic-quality MRI imaging for real-time tissue tracking and automated beam control during cancer treatment. The system is used by hospitals and cancer centers to treat pancreas, prostate, lung, liver, breast, and oligometastatic cancers.
- Who founded Viewray?
- Viewray was founded by James F. Dempsey in 2013.
- Who are Viewray's investors?
- Viewray's investors include Aisling Capital, F-Prime Capital, OrbiMed.
- How much funding has Viewray raised?
- Viewray has disclosed $126.9M raised across 7 of its 8 known rounds.
- Where is Viewray headquartered?
- Viewray is headquartered in Oakwood Village, US.